Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cannon

Showing results (91-100 of 1,137) with videos related to

Pageof 114
Sort By:
European Heart Journal|March 17, 2011
Myocardial infarction vaccine? Evidence supporting the influenza vaccine for secondary preventionPradeep Natarajan, Christopher P Cannon
Reviews in Cardiovascular Medicine|January 6, 2009
Percutaneous coronary intervention. Cardiovascular outcomes and long-term clopidogrel use after PCI in patients with diabetesChristopher P Cannon, Subroto Acharjee
Mayo Clinic Proceedings|October 3, 2009
Acute coronary syndromes: diagnosis and management, part IAmit Kumar, Christopher P Cannon
Acta Cardiologica|January 1, 1994
GUSTO, TIMI and the case for rapid reperfusionC P Cannon, E Braunwald
The Medical Clinics of North America|March 7, 2012
Triglycerides: how much credit do they deserve?Payal Kohli, Christopher P Cannon
Critical Pathways in Cardiology|March 15, 2008
Strategies and Therapies for Reducing Ischemic and Vascular Events (STRIVE) acute coronary syndromes Critical Pathway ToolkitChristopher P Cannon, Eugene Braunwald,
Critical Pathways in Cardiology|October 13, 2011
Dabigatran: a new option for anticoagulation in atrial fibrillation and venous thromboembolismSubroto Acharjee, Christopher P Cannon
Lancet (London, England)|November 26, 2011
Statins and safety: can we finally be reassured?Payal Kohli, Christopher P Cannon
Journal of the American College of Cardiology|May 1, 1996
Non-Q wave and ST segment depression myocardial infarction: is there a role for thrombolytic therapy?E Braunwald, C P Cannon
Reviews in Cardiovascular Medicine|August 12, 2010
News and views from the literature. Antiplatelet therapy. Ticagrelor in acute coronary syndrome: a new frontier in platelet inhibitionAmit Kumar, Christopher P Cannon
Pageof 114

Showing results (91-100 of 1,137) with videos related to

Sort By:
Pageof 114
European Heart Journal|March 17, 2011
Myocardial infarction vaccine? Evidence supporting the influenza vaccine for secondary preventionPradeep Natarajan, Christopher P Cannon
Reviews in Cardiovascular Medicine|January 6, 2009
Percutaneous coronary intervention. Cardiovascular outcomes and long-term clopidogrel use after PCI in patients with diabetesChristopher P Cannon, Subroto Acharjee
Mayo Clinic Proceedings|October 3, 2009
Acute coronary syndromes: diagnosis and management, part IAmit Kumar, Christopher P Cannon
Acta Cardiologica|January 1, 1994
GUSTO, TIMI and the case for rapid reperfusionC P Cannon, E Braunwald
The Medical Clinics of North America|March 7, 2012
Triglycerides: how much credit do they deserve?Payal Kohli, Christopher P Cannon
Critical Pathways in Cardiology|March 15, 2008
Strategies and Therapies for Reducing Ischemic and Vascular Events (STRIVE) acute coronary syndromes Critical Pathway ToolkitChristopher P Cannon, Eugene Braunwald,
Critical Pathways in Cardiology|October 13, 2011
Dabigatran: a new option for anticoagulation in atrial fibrillation and venous thromboembolismSubroto Acharjee, Christopher P Cannon
Lancet (London, England)|November 26, 2011
Statins and safety: can we finally be reassured?Payal Kohli, Christopher P Cannon
Journal of the American College of Cardiology|May 1, 1996
Non-Q wave and ST segment depression myocardial infarction: is there a role for thrombolytic therapy?E Braunwald, C P Cannon
Reviews in Cardiovascular Medicine|August 12, 2010
News and views from the literature. Antiplatelet therapy. Ticagrelor in acute coronary syndrome: a new frontier in platelet inhibitionAmit Kumar, Christopher P Cannon
Pageof 114